Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Drug Industry

Article Abstract:

Improving fundamentals account for the advance of the drug industry although it has its share of troubled companies like Bristol-Myers Squibb, and Schering-Plough. Rising consumer confidence, weakening dollar and aggressive drug makers are boosting growth through price increases.

Author: Rho, George
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Legal issues & crime, Forecasts, trends, outlooks, Financial management, Securities issued, listed, Labor Distribution by Employer, Company legal issue, Cases, Finance, Company investment, Investments, Investigations, Statistics, Securities, Bristol-Myers Squibb Co., Schering-Plough Corp., BMY, SGP, Company securities, Company financing, Company business forecast/projection, Company forecasts, Industry forecasts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Drug industry

Article Abstract:

Large scale investment in biotechnology stocks compared with relatively little movement in the older pharmaceutical companies has been reversed recently. Includes details of related companies.

Author: Rho, George
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2000
Management, Biotechnology industry, Biotechnology industries, Prices and rates

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Drug industry

Article Abstract:

Drug industry stocks should be evaluated individually for investment purposes.

Author: Rho, George, Ferro, Mario, Schlein, Milton, Harris, Frederick L., III, Clark, Charles, Butler, Jeremy J., Markey, Keith A., Rosner, Adam, Ferrara, J. Susan, Chow, Nancy
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
France, High technology industry, Economic aspects, Aventis Pasteur S.A., Abgenix Inc., ABGX, Andrx Corp., ADRX, Albany Molecular Research Inc., AMRI

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Pharmaceutical industry
Similar abstracts:
  • Abstracts: Textile industry. part 4
  • Abstracts: Retail store industry. part 4
  • Abstracts: Soft drink industry. part 3
  • Abstracts: Chemical (basic) industry. part 4
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.